Efficacy of metronomic oral cyclophosphamide with low dose dexamethasone and celecoxib in metastatic castration-resistant prostate cancer
Author:
Affiliation:
1. Department of Medicine; Asan Medical Centre, University of Ulsan College of Medicine; Seoul South Korea
2. Department of Oncology; Asan Medical Centre; University of Ulsan College of Medicine; Seoul South Korea
Funder
Korean Health Technology R&D Project
Ministry of Health and Welfare
Publisher
Wiley
Subject
Oncology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12583/fullpdf
Reference29 articles.
1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014
2. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011;Jung;Cancer Res Treat,2014
3. Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program;Lee;Cancer Chemother Pharmacol,2014
4. Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial;Tannock;Lancet Oncol,2013
5. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. “Cyclophosphamide and analogues; a matter of dose and schedule for dual anticancer activities”;Cancer Letters;2024-08
2. Parthenolide enhances the metronomic chemotherapy effect of cyclophosphamide in lung cancer by inhibiting the NF-kB signaling pathway;World Journal of Clinical Oncology;2024-07-24
3. Challenges and Opportunities for Celecoxib Repurposing;Pharmaceutical Research;2023-08-08
4. Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer;BMC Cancer;2023-04-04
5. A study to assess the health effects of an anticancer drug (cyclophosphamide) in zebrafish (Danio rerio): eco-toxicity of emerging contaminants;Environmental Science: Processes & Impacts;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3